Duke University School of Medicine, Durham, NC 27701, USA.
Am J Manag Care. 2010 Dec;16(12 Suppl HIT):e320-6.
To determine whether electronic prescribing transaction data can be used to accurately and efficiently track national and regional electronic health record (EHR) adoption in order to evaluate progress toward national goals and identify and address regional disparities.
This study compared national EHR use estimates derived from Surescripts electronic prescribing data for 2007 and 2008 with contemporary National Ambulatory Medical Care Survey (NAMCS) estimates.
The ratio of relative risks was adapted to test the statistical significance of the difference in the differences between Surescripts and NAMCS estimates in 2007 and 2008.
In 2007, the relative ratio (RR) of NAMCS to Surescripts data was 3.73 (95% confidence interval [CI] = 3.27, 4.26). In 2008, the RR was 2.06 (95% CI = 1.75, 2.42). The ratio of RRs for 2007 compared with 2008 was 1.81 (P <.0001), suggesting that Surescripts transactional data for providers prescribing through an EHR is becoming better aligned with accepted measures of EHR adoption in the United States with time. Surescripts-derived state estimates for EHR use ranged from less than 8% (North Dakota, New Jersey, New Mexico) to more than 37% (Minnesota, Wisconsin, Massachusetts, Iowa).
Surescripts transactional data may allow for the ongoing identification of regional trends and assist policy makers in identifying and mitigating emerging disparities in EHR adoption. Further analysis is needed to ensure that Surescripts data continue to correlate with NAMCS results for 2009-2010.
确定电子处方交易数据是否可用于准确、高效地跟踪国家和地区电子健康记录 (EHR) 的采用情况,以便评估国家目标的进展情况,发现并解决地区差异。
本研究比较了 2007 年和 2008 年 Surescripts 电子处方数据得出的全国 EHR 使用估计值与当代全国门诊医疗调查 (NAMCS) 估计值。
采用相对风险比来检验 Surescripts 和 NAMCS 2007 年和 2008 年估计值之间差异的差异的统计学显著性。
2007 年,NAMCS 与 Surescripts 数据的相对比值 (RR) 为 3.73(95%置信区间 [CI] = 3.27,4.26)。2008 年,RR 为 2.06(95% CI = 1.75,2.42)。2007 年与 2008 年的 RR 比值为 1.81(P<.0001),表明随着时间的推移,通过 EHR 开处方的提供商的 Surescripts 交易数据与美国公认的 EHR 采用衡量标准越来越吻合。Surescripts 得出的 EHR 使用州估计值从不到 8%(北达科他州、新泽西州、新墨西哥州)到超过 37%(明尼苏达州、威斯康星州、马萨诸塞州、爱荷华州)不等。
Surescripts 交易数据可能允许持续识别区域趋势,并帮助政策制定者发现和减轻 EHR 采用方面的新出现的差异。需要进一步分析以确保 Surescripts 数据继续与 2009-2010 年 NAMCS 结果相关。